-
Mashup Score: 62Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance–Guided Radiotherapy - 12 day(s) ago
This cohort study examines the rates of toxic effects following cancer treatment with high-field magnetic resonance–guided radiotherapy, in particular online adaptive workflows in which the radiation plan is tailored to MR-visualized anatomy at each session.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1The SAMURAI Study's Role in Evolving Radiation Therapy for Kidney Cancer - Rana McKay & William Hall - 11 month(s) ago
Alicia Morgans hosts a discussion with William Hall and Rana McKay to discuss SAMURAI, the first cooperative group study that randomizes patients with kidney cancer between radiation and no radiation. Dr. Hall points out how radiation therapy has evolved over the past 15 years, offering high doses with millimeter accuracy that precisely targets malignancy while avoiding normal tissue. This…
Source: UroTodayCategories: Hem/Oncs, Latest HeadlinesTweet-
https://t.co/lriIL7pHXR via @urotoday
-
-
Mashup Score: 0Program Guide – ASCO Meeting Program Guide - 11 month(s) ago
AuthorsDeborah SchragMemorial Sloan Kettering Cancer Center, New York, NYDeborah Schrag, Qian Shi, Martin R. Weiser, Marc J Gollub, Leonard B. Saltz, Benjamin Leon Musher, Joel Goldberg, Tareq Al Baghdadi, Karyn A. Goodman, Robert R. McWilliams, Jeffrey M. Farma, Thomas J. George, Hagen Fritz Kennecke, Alan P. Venook, Eileen Mary O’Reilly, Jeffrey A. Meyerhardt, Amylou C. Dueck, Ethan Basch,…
Source: meetings.asco.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Program Guide – ASCO Meeting Program Guide https://t.co/lE0m9D1ImT
-
-
Mashup Score: 0NRG-GU012, the "SAMURAI" Study Overview - 1 year(s) ago
Dr. William Hall (PI) discusses the NRG-NRG-GU012 “SAMURAI” study: Randomized Phase II Stereotactic Ablative Radiation Therapy (SABR) For Metastatic Unresect…
Source: YouTubeCategories: Latest Headlines, Oncologists2Tweet-
NRG-GU012, the "SAMURAI" Study Overview https://t.co/iHRzNqmMyT via @YouTube
-
-
Mashup Score: 1
Stereotactic ablative body radiotherapy (SABR) is associated with good oncological outcomes and a favourable toxicity profile in patients with localised renal cell carcinoma (RCC). Intriguing multimodality approaches, which include SABR in the operable setting, are emerging. In the context of metastatic RCC, SABR alone or in combination with systemic treatment has shown promising clinical…
Source: European UrologyCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @EUplatinum: Editor's Choice: The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma https://t.co/7yuijmEPOL @l…
-
-
Mashup Score: 0Remembering Jerome C. Landry, MD, MBA - 1 year(s) ago
In July, the field of radiation oncology lost an expert and pioneer
Categories: Hem/Oncs, Latest HeadlinesTweet-
Remembering Jerome C. Landry, MD, MBA - News from the ECOG-ACRIN Cancer Research Group https://t.co/CMeDimwPNu
-
-
Mashup Score: 7Cancer patient creates doctor coats for treatment team - 2 year(s) ago
“All they need to do is keep me alive, and I’ll keep drawing.”
Categories: Latest Headlines, Oncologists2Tweet-
Beyond thrilled to receive this gift, amazed by his artistic abilities! News story linked below. @MCWRadOnc @MCWCancerCenter @NRGonc https://t.co/jdCLO3o51h
-
-
Mashup Score: 2Join me at Bank of America Chicago Marathon - 2 year(s) ago
I’m supporting the American Cancer Society to honor those touched by cancer by raising funds for groundbreaking research. Support me.
Source: secure.acsevents.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
October 9th, 2022 I am running the @BankofAmerica @ChiMarathon to raise money for @AmericanCancer a link to donate to my team is below, so thrilled to be doing this. To date we have raised over $12,000 for @AmericanCancer please consider donating! Thanks! https://t.co/H1Fo9qd6t9 https://t.co/97lmAc5Yyt
-
-
Mashup Score: 2NRG-GU012: Radiation and Immune Therapy for Renal Cell Cancer - 2 year(s) ago
Currently Available for Patients About This Study NRG-GU012, also known as “the SAMURAI study”, is a clinical study for people with renal cell cancer that has spread beyond the kidneys, also known as metastatic renal cell cancer. This trial…
Source: www.nrgoncology.orgCategories: Latest Headlines, Oncologists2Tweet-
RT @NRGonc: The SAMURAI Study (NRG-GU012) patient study webpage is NOW LIVE at https://t.co/c3cndm7Kb3 - Learn more about this trial for re…
-
-
Mashup Score: 0Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic Adenocarcinoma - 2 year(s) ago
Section:IntroductionSupport for the role of neoadjuvant therapy in the management of nonmetastatic pancreatic adenocarcinoma is growing. With the high risk of rapid dissemination of disease, neoadjuvant therapy allows for the immediate delivery of systemic therapy to address micrometastatic disease present in most patients with localized pancreatic cancer at the time of diagnosis. This strategy…
Source: Journal of Clinical OncologyCategories: Hem/Oncs, Latest HeadlinesTweet-
@KarynAGoodman Thanks for initiating this important discussion @CathyEngMD @KarynAGoodman, myself, and many other collaborators have written about this controversial point recently, link below, this may be of interest as people consider existing data: https://t.co/blEdEgjOkb
-
Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance–Guided Radiotherapy | Oncology | JAMA Network Open | JAMA Network https://t.co/lDWfRSxBHX